The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Oral antihyperglycemic therapy for type 2 diabetes mellitus
Open accessAbstract
Diabetes mellitus is a chronic disease that is growing in prevalence worldwide. Pharmacologic therapy is often necessary to achieve optimal glycemic control in the management of diabetes. Orally administered antihyperglycemic agents (OHAs) can be used either alone or in combination with other OHAs or insulin. The number of available OHAs has increased significantly in the last decade, which translates into more therapeutic options and complex decision-making for physicians. This review article is designed to help with these decisions. We review the mechanism of action, efficacy and side effects of the different classes of OHAs (alpha-glucosidase inhibitors, biguanides, insulin secretagogues, insulin sensitizers and intestinal lipase inhibitor) and discuss the current recommendations for their use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N., & Shichiri, M. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01064-k · Cited by 3,079
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
Fuller, N. R., Colagiuri, S., Schofield, D., Olson, A. D., Shrestha, R., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.139 · Cited by 2,117
XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.155 · Cited by 1,915
Bailey, C. J., & Turner, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602293340906 · Cited by 1,726
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., & for The STOP-NIDDM Trial Research Group (2003) · JAMA · doi:10.1001/jama.290.4.486 · Cited by 1,624
Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339
Booth, G., & Cheng, A. Y. Y. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.010 · Cited by 1,220
Self-citationMetabolic effects of metformin in non-insulin-dependent diabetes mellitus
Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G., & Gerich, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330903 · Cited by 1,148
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084
Oral Antihyperglycemic Therapy for Type 2 Diabetes: Scientific Review
Inzucchi, S. E. (2002) · JAMA · doi:10.1001/jama.287.3.360 · Cited by 1,065
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Salpeter, S. R., Greyber, E., Pasternak, G. A., & Salpeter (posthumous), E. E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002967.pub4 · Cited by 893
Minireview: Lipid Metabolism, Metabolic Diseases, and Peroxisome Proliferator-Activated Receptors
Lee, C.-H., Olson, P., & Evans, R. M. (2003) · Endocrinology · doi:10.1210/en.2003-0288 · Cited by 890
Protein–protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
Virkamäki, A., Ueki, K., & Kahn, C. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6609 · Cited by 854 · cited 1×
“pathways are believed to play a role.(9,10) Insulin resistance, which is usually present before the onset of diabetes, is determined by a number of factors, including genetics, age, obesity and, later in the disease, hyperglycemia itself.”
BackgroundNesto, R. W., Bell, D., Bonow, R. O., Fonseca, V., Grundy, S. M., Horton, E. S., Le Winter, M., Porte, D., Semenkovich, C. F., Smith, S., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103683.99399.7e · Cited by 829
Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus
Inzucchi, S. E., Maggs, D. G., Spollett, G. R., Page, S. L., Rife, F. S., Walton, V., & Shulman, G. I. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381303 · Cited by 794
Cheng, A. Y. Y. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.009 · Cited by 728
Self-citation[The Da Qing IGT and Diabetes study].
Ayame, H. (2005) · PubMed · Cited by 658
Hollander, P. A., Elbein, S. C., Hirsch, I. B., Kelley, D., McGill, J., Taylor, T., Weiss, S. R., Crockett, S. E., Kaplan, R. A., Comstock, J., et al. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1288 · Cited by 654
Aronoff, S., Rosenblatt, S., Braithwaite, S., Egan, J. W., Mathisen, A. L., & Schneider, R. L. (2000) · Diabetes Care · doi:10.2337/diacare.23.11.1605 · Cited by 629
Lebovitz, H. E. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70266-8 · Cited by 563
Efficacy of Metformin in Type II Diabetes
Garber, A. J., Duncan, T. G., Goodman, A. M., Mills, D. J., & Rohlf, J. L. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00254-4 · Cited by 519
Rosiglitazone Monotherapy Is Effective in Patients with Type 2 Diabetes
Lebovitz, H. E., Dole, J., Patwardhan, R., Rappaport, E. B., & Freed, M. I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.280 · Cited by 518
Kashyap, S., Belfort, R., Gastaldelli, A., Pratipanawatr, T., Berria, R., Pratipanawatr, W., Bajaj, M., Mandarino, L., DeFronzo, R., & Cusi, K. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2461 · Cited by 503
Holmes, B. F., Kurth-Kraczek, E. J., & Winder, W. W. (1999) · Journal of Applied Physiology · doi:10.1152/jappl.1999.87.5.1990 · Cited by 489
&NA; (1994) · Survey of Anesthesiology · doi:10.1097/00132586-199406000-00052 · Cited by 487
Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects
DEFRONZO, R. A., BARZILAI, N., & SIMONSON, D. C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-6-1294 · Cited by 408
β-Cell Mass Dynamics in Zucker Diabetic Fatty Rats
Finegood, D. T., McArthur, M. D., Kojwang, D., Thomas, M. J., Topp, B. G., Leonard, T., & Buckingham, R. E. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1021 · Cited by 374
Absence of Cross-Reactivity between Sulfonamide Antibiotics and Sulfonamide Nonantibiotics
Strom, B. L., Schinnar, R., Apter, A. J., Margolis, D. J., Lautenbach, E., Hennessy, S., Bilker, W. B., & Pettitt, D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022963 · Cited by 349
Guerciolini, R. (1997) · PubMed · Cited by 331
Kelly, I. E., Han, T. S., Walsh, K., & Lean, M. E. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.288 · Cited by 315
Kelley, D. E., Bray, G. A., Pi-Sunyer, F. X., Klein, S., Hill, J., Miles, J., & Hollander, P. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.1033 · Cited by 314
Metformin Reduces Serum C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome
Morin-Papunen, L., Rautio, K., Ruokonen, A., Hedberg, P., Puukka, M., & Tapanainen, J. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021688 · Cited by 245
Rosiglitazone reduces urinary albumin excretion in type II diabetes
Bakris, G., Viberti, G., Weston, W. M., Heise, M., Porter, L. E., & Freed, M. I. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001444 · Cited by 240
Adipokines, inflammation, and the endothelium in diabetes
Aldhahi, W., & Hamdy, O. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0020-2 · Cited by 232
LANDIN, K., TENGBORN, L., & SMITH, U. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00328.x · Cited by 225
Klepzig, H. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1242 · Cited by 224
Mg, G. (1971) · JAMA · doi:10.1001/jama.218.9.1400 · Cited by 221
The Diabetes Prevention Program Research Group (2003) · Diabetes Care · doi:10.2337/diacare.26.4.977 · Cited by 218
Metformin and lactic acidosis: cause or coincidence? A review of case reports
Stades, A. M. E., Heikens, J. T., Erkelens, D. W., Holleman, F., & Hoekstra, J. B. L. (2004) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01271.x · Cited by 196
Repaglinide versus glyburide: a one-year comparison trial
Marbury, T., Huang, W.-C., Strange, P., & Lebovitz, H. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00002-9 · Cited by 185
Clinical Pharmacokinetics and Pharmacodynamics of Repaglinide
Hatorp, V. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241070-00002 · Cited by 151
Hanefeld, M., & Sachse, G. (2002) · Diabetes, Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00237.x · Cited by 151
Pancreatic beta-cell loss and preservation in type 2 diabetes
Buchanan, T. A. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80241-2 · Cited by 149
Hoffmann, J., & Spengler, M. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00252-0 · Cited by 148
Garber, A. J., Larsen, J. L., Schneider, S. H., Piper, B. A., Henry, D. A., & The Glyburide/Metformin Initial Therapy Study Group (2002) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00211.x · Cited by 144
Horton, E. S., Whitehouse, F. W., Ghazzi, M. N., Venable, T. C., The Troglitazone Study Group, & Whitcomb, R. W. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1462 · Cited by 138
Hanefeld, M., Bouter, K. P., Dickinson, S., et al. (2000) · Diabetes Care · doi:10.2337/diacare.23.2.202 · Cited by 137
Clinical Evaluation of Glimepiride versus Glyburide in NIDDM in a Double-Blind Comparative Study
Dills, D. G., & Schneider, J. (1996) · Hormone and Metabolic Research · doi:10.1055/s-2007-979831 · Cited by 134
Herz, M., Johns, D., Reviriego, J., Grossman, L. D., Godin, C., Durán, S., Hawkins, F. G., Lochnan, H. A., Escobar‐Jiménez, F., Hardin, P. A., et al. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80068-1 · Cited by 132
Särnblad, S., Kroon, M., & Åman, J. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490323 · Cited by 123
Zimmerman, B. R. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70264-4 · Cited by 121
Glibenclamide vs Gliclazide in Type 2 Diabetes of the Elderly
Tessier, D., Dawson, K., Tétrault, J. P., Bravo, G., & Meneilly, G. S. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00256.x · Cited by 116
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Salpeter, S. R., Greyber, E., Pasternak, G. A., & Salpeter, E. E. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002967 · Cited by 113
Clinical Pharmacokinetics of Nateglinide: A Rapidly-Absorbed, Short-Acting Insulinotropic Agent
McLeod, J. F. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443020-00003 · Cited by 111
Hatorp, V., Hansen, K. T., & Thomsen, M. S. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003253704 · Cited by 110
Firth, R. G., Bell, P. M., & Rizza, R. A. (1987) · Metabolism · doi:10.1016/0026-0495(87)90031-x · Cited by 102
Inhibitory effect of metformin on intestinal glucose absorption in the perfused rat intestine
Ikeda, T., Iwata, K., & Murakami, H. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00396-2 · Cited by 97
Lawson, M. L., Gerstein, H. C., Tsui, E. Y. L., & Zinman, B. (1999) · PubMed · Cited by 87
Hermann, L. S., Scherstén, B., & Melander, A. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00253.x · Cited by 86
Tessier, D., Maheux, P., Khalil, A., & Fülöp, T. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90226-3 · Cited by 84
Oral Antihyperglycemic Therapy for Type 2 Diabetes
Holmboe, E. S. (2002) · JAMA · doi:10.1001/jama.287.3.373 · Cited by 80
ORAL THERAPIES FOR DIABETIC HYPERGLYCEMIA
Lebovitz, H. E. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70221-8 · Cited by 79
Meyer, L., Böhme, P., Delbachian, I., Lehert, P., Cugnardey, N., Drouin, P., & Guerci, B. (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2153 · Cited by 76
Bayraktar, M., Thiel, D. H. V., & Adalar, N. (1996) · Diabetes Care · doi:10.2337/diacare.19.3.252 · Cited by 75
Abbasi, F., Kamath, V., Rizvi, A. A., Carantoni, M., Chen, Y. I., & Reaven, G. M. (1997) · Diabetes Care · doi:10.2337/diacare.20.12.1863 · Cited by 68
Management of diabetes mellitus and insulin resistance in patients with cardiovascular disease
Fonseca, V. A. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00616-7 · Cited by 67
β-Cell rejuvenation with thiazolidinediones
Bell, D. S. H. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.010 · Cited by 63
Nattrass, M., & Lauritzen, T. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0801422 · Cited by 61
The status of metformin in Canada.
Lucis, O. J. (1983) · PubMed · Cited by 59
Rosenstock, J., Shen, S. G., Gatlin, M. R., & Foley, J. E. (2002) · Diabetes Care · doi:10.2337/diacare.25.9.1529 · Cited by 49
Horton, E. S., Foley, J. E., Shen, S. G., & Baron, M. A. (2004) · Current Medical Research and Opinion · doi:10.1185/030079903125003881 · Cited by 41
Kilo, C., Miller, J. D., & Williamson, J. R. (1980) · Diabetologia · doi:10.1007/bf00251913 · Cited by 16
Cited by
Multi-target therapeutics: when the whole is greater than the sum of the parts
Zimmermann, G. R., Lehár, J., & Keith, C. T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.008 · Cited by 1,105
α-Amylase Inhibitors: A Review of Raw Material and Isolated Compounds from Plant Source
Sales, P. M., Souza, P. M., Simeoni, L. A., Magalhães, P. O., & Silveira, D. (2012) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j35s3k · Cited by 599
Matthews, D. R., Paldánius, P. M., Proot, P., Chiang, Y., Stumvoll, M., & Del Prato, S. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32131-2 · Cited by 364
Resveratrol and diabetes: from animal to human studies
Szkudelski, T., & Szkudelska, K. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.013 · Cited by 354
Potent α-amylase inhibitory activity of Indian Ayurvedic medicinal plants
P, S., Zinjarde, S. S., Bhargava, S. Y., & Kumar, A. R. (2011) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-11-5 · Cited by 353
Metadata
- Authors
- Cheng, A. Y. Y.
- Venue
- Canadian Medical Association Journal
- Publisher
- CMA Joule Inc.
- Published
- 2005-01-18
- Volume
- 172
- Issue
- 2
- Pages
- 213-226
- ISSN
- 0820-3946 (ISSN-L)
- 1488-2329
- OpenAlex
- W2018075481
- Cited by
- 502
- References
- 88
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.